(Q68809659)
Statements
High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings (English)
M T Lotze
A E Chang
C A Seipp
C Simpson
J T Vetto
S A Rosenberg
1 December 1986